Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Haiyan Wang has a total of 23 co-authors. Here are the top co-authors by number of shared publications:

  • Qiaoyun Gong

    Department of Ophthalmology, Shanghai General Hospital, Shanghai 200080, China

    5 shared publications
  • Jingyi Wang

    Precision Research Center for Refractory Diseases, Shanghai Jiao Tong University Pioneer Research Institute for Molecular and Cell Therapies, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

    3 shared publications
  • Zihan Yin

    Department of Ophthalmology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, National Clinical Research Center for Eye Diseases, Shanghai Key Laboratory of Ocular Fundus Diseases, Shanghai Engineering Center for Visual Science and Photomedicine, Shanghai engineering center for precise diagnosis and treatment of eye diseases, China

    3 shared publications
  • Junwei Fang

    Department of Ophthalmology, Shanghai General Hospital, Shanghai Jiao Tong University, Shanghai, China

    2 shared publications
  • Rulin Zhang

    Department of Laboratory Medicine, Shanghai General Hospital, Shanghai, China

    2 shared publications
  • Yupeng Xu

    Department of Ophthalmology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, National Clinical Research Center for Eye Diseases, Shanghai Key Laboratory of Ocular Fundus Diseases, Shanghai Engineering Center for Visual Science and Photomedicine, Shanghai engineering center for precise diagnosis and treatment of eye diseases, China

    2 shared publications

Latest Publications

  • Open Access

    Targeting the PPAR-γ/OPTN axis to inhibit apoptosis in steroid-induced glaucoma

    by Xin Liang, Ning Li, Qiaoyun Gong, Haiyan Wang

  • Open Access

    ePWV as a scalable risk factor for large-scale glaucoma screening: evidence from a national Chinese cohort

    by Yupeng Xu, Zihan Yin, Qiaoyun Gong, Mingjie Zhu, Chuming Lu, Haiyan Wang

    Background: To examine the association between estimated pulse wave velocity (ePWV), a marker of arterial stiffness, and glaucoma incidence in Chinese cohort, highlighting ePWV’s potential as a scalable population-level risk factor for glaucoma screening. Materials and methods: Data were obtained from the China Health and Retirement Longitudinal Study (CHARLS). A total of 11,968 adults aged ≥45 years without glaucoma at baseline (2011–2018) were followed for up to 7 years ePWV was calculated from age and blood pressure and divided into quartiles. Cox proportional hazards models assessed risk, while restricted cubic spline and two-piecewise models explored dose–response patterns. Subgroup analyses tested effect modification by demographic and lifestyle factors. Results: During a 7-year follow-up, participants in the highest ePWV quartile (≥10.58 m/s) had a higher risk of glaucoma compared with the lowest quartile (<8.01 m/s) (HR [hazard ratio] 1.39, 95% CI [confidence interval] 1.00–1.93). Each 1 m/s increase in ePWV was associated with a 7% higher glaucoma risk (HR 1.07, 95% CI 1.01–1.13). The dose response relationship was linear without evidence of a threshold. Associations were consistent across most subgroups. Sensitivity analyses showed that ePWV was a stronger predictor of glaucoma than age or blood pressure alone. Conclusion: Higher ePWV independently links to greater glaucoma risk in middle-aged and older Chinese. This observed association indicates that ePWV provides incremental predictive value beyond traditional demographic or clinical factors. Building on this characteristic, incorporating ePWV into future artificial intelligence (AI)-enabled glaucoma screening models may potentially contribute to improving risk-stratification accuracy and facilitating early identification of high-risk individuals.


  • Open Access

    BCAT1 Activation Reprograms Branched-Chain Amino Acid Metabolism and Epigenetically Promotes Inflammation in Diabetic Retinopathy

    by Jingyi Wang, Zihan Yin, Jingxiao Yang, Sijun Sun, Xiaofang Tang, Shengjie Zhang, Yi-Ping Wang, Haiyan Wang

    To investigate how branched-chain amino acid (BCAA) metabolism is remodeled and to determine its contribution to diabetic retinopathy progression. We analyzed Bcat1 and Bcat2 expression in the retina using single-cell sequencing data and immunofluorescence. Bcat1-mediated remodeling of BCAA metabolism was assessed via targeted metabolomics in Müller cells. We performed chromatin immunoprecipitation (ChIP) to examine histone methylation at inflammatory gene promoters. Additionally, we utilized RNA sequencing and kinase screening assays to delineate phosphorylation regulation of Bcat1 activity. In vivo, we established diabetic mouse models and treated them with Bcat1-specific inhibitor to evaluate retinal inflammation and vascular leakage. Bcat1 was predominantly expressed in Müller cells and exhibited increased activity under diabetic conditions, leading to a remodeling of BCAA catabolism and upregulation of inflammatory genes (interleukin 6 [Il6] and tumor necrosis factor-α [Tnf-α]). Bcat1 activity was negatively regulated by polo-like kinase 4 (Plk4)-mediated phosphorylation at threonine 333. In high glucose-treated Müller cells, elevated Bcat1 activity reduced α-ketoglutarate (α-KG), a critical substrate for histone demethylation reactions, resulting in higher histone H3 lysine 4 trimethylation (H3K4me3) levels at inflammatory gene promoters, and further boosted retinal inflammation. Treatment with chemical Bcat1 inhibitors (BAY-069 and ERG240) significantly reduced inflammatory gene expression and vascular leakage in diabetic retinas in vivo. Bcat1 activation mediates BCAA metabolism remodeling in Müller cells and epigenetically induces retinal inflammation, which offers a potential therapeutic target for diabetic retinopathy. Diabetes and diabetic retinopathy are potentially driven not only by hyperglycemia but also by dysregulated amino acid metabolism.


  • Open Access

    Accumulation of branched-chain amino acids deteriorates the neuroinflammatory response of Müller cells in diabetic retinopathy via leucine/Sestrin2-mediated sensing of mTOR signaling

    by Qiaoyun Gong, Jingyi Wang, Dawei Luo, Yupeng Xu, Rulin Zhang, Xin Li, Zihan Yin, Junwei Fang, Haiyan Wang

    Aims: This study aimed to investigate branched-chain amino acid (BCAA) catabolism in diabetic retinopathy (DR). Methods: Wild-type and db/db mice were fed BCAAs (5 or 10 mg/kg/day) for 12 weeks, and hyperglycemia-exposed Müller cells were treated with BCAAs (2 or 5 mmol/L) for 24 and 48 h. BCAA levels were measured using MS/MS. Western blotting was performed to detect proteins. Flow cytometry, oxygen consumption rate, and Cell Counting Kit-8 assays were used to evaluate Müller cell viability. Each experiment was conducted at least thrice. Results: BCAAs and branched-chain α-keto acids (BCKAs) were increased in the retina and systemic tissues of diabetic mice, and these changes were further enhanced to approximately 2-fold by extra BCAAs compared to wild-type group. In vitro, BCAAs and BCKAs were induced in hyperglycemic Müller cells, and augmented by BCAA supplementation. The aberrant BCAA catabolism was accompanied by mTORC1 activation and subsequently induced TNF-ɑ, VEGFA, GS, and GFAP in retinas and Müller cells under diabetic conditions. The cell apoptosis rate increased by approximately 50%, and mitochondrial respiration was inhibited by hyperglycemia and BCAA in Müller cells. Additionally, mTORC1 signaling was activated by leucine in Müller cells. Knockdown of Sestrin2 or LeuRS significantly abolished the leucine-induced mTORC1 phosphorylation and protected Müller cell viability under diabetic conditions. Conclusions: We found that BCAA catabolism is hindered in DR through mTORC1 activation. Leucine plays a key role in inducing mTORC1 by sensing Sestrin2 in Müller cells. Targeting Sestrin2 may ameliorate the toxic effects of BCAA accumulation on Müller cells in DR.


  • Open Access

    Potential Immune-Inflammatory Proteome Biomarkers for Guiding the Treatment of Patients with Primary Acute Angle-Closure Glaucoma Caused by COVID-19

    by Qiaoyun Gong, Mingshui Fu, Jingyi Wang, Shuzhi Zhao, Haiyan Wang

    Primary acute angle-closure glaucoma (PAACG) is a sight-threatening condition that can lead to blindness. With the increasing incidence of COVID-19, a multitude of people are experiencing acute vision loss and severe swelling of the eyes and head. These patients were then diagnosed with acute angle closure, with or without a history of PACG. However, the mechanism by which viral infection causes PACG has not been clarified. This is the first study to explore the specific inflammatory proteomic landscape in SARS-CoV-2-induced PAACG. The expression of 92 inflammation-related proteins in 19 aqueous humor samples from PAACGs or cataract patients was detected using the Olink Target 96 Inflammation Panel based on a highly sensitive and specific proximity extension assay technology. The results showed that 76 proteins were significantly more abundant in the PAACG group than in the cataract group. Notably, the top eight differentially expressed proteins were IL-8, MCP-1, TNFRSF9, DNER, CCL4, Flt3L, CXCL10, and CD40. Generally, immune markers are related to inflammation, macrophage activation, and viral infection, revealing the crucial role of macrophages in the occurrence of PAACGs caused by SARS-CoV-2.